Cutanogen Overview
- Founded
-
1997
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Cutanogen General Information
Description
Provider of biotechnology services. The company focuses on products such as PermaDerm and has license to develop engineered skin substitutes that are used to treat patients with severe burns.
Contact Information
Website
www.cutanogen.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 3130 Highland Avenue
- Suite 3420
- Cincinnati, OH 45219
- United States
Cutanogen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cutanogen Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|